In addition, a p53 inhibitor, Pifithrin-α, completely prevented the ability of LbGP in inhibiting CT26 cell proliferation (Figure S2), further supporting our findings that LbGP’s anti-tumor effects were via upregulating the p53 signaling pathway. The gene discussed is TP53; the disease is neoplasm.